» Articles » PMID: 32503578

Genome-wide Association Study Identifies Genetic Susceptibility Loci and Pathways of Radiation-induced Acute Oral Mucositis

Abstract

Background: Radiation-induced oral mucositis (OM) is one of the most common acute complications for head and neck cancer. Severe OM is associated with radiation treatment breaks, which harms successful tumor management. Radiogenomics studies have indicated that genetic variants are associated with adverse effects of radiotherapy.

Methods: A large-scale genome-wide scan was performed in 1467 nasopharyngeal carcinoma patients, including 753 treated with 2D-CRT from Genetic Architecture of the Radiotherapy Toxicity and Prognosis (GARTP) cohort and 714 treated with IMRT (192 from the GARTP and 522 newly recruited). Subgroup analysis by radiotherapy technique was further performed in the top associations. We also performed physical and regulatory mapping of the risk loci and gene set enrichment analysis of the candidate target genes.

Results: We identified 50 associated genomic loci and 64 genes via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping and gene-based analysis, and 36 of these loci were replicated in subgroup analysis. Interestingly, one of the top loci located in TNKS, a gene relevant to radiation toxicity, was associated with increased OM risk with OR = 3.72 of the lead SNP rs117157809 (95% CI 2.10-6.57; P = 6.33 × 10). Gene set analyses showed that the 64 candidate target genes were enriched in the biological processes of regulating telomere capping and maintenance and telomerase activity (Top P = 7.73 × 10).

Conclusions: These results enhance the biological understanding of radiotherapy toxicity. The association signals enriched in telomere function regulation implicate the potential underlying mechanism and warrant further functional investigation and potential individual radiotherapy applications.

Citing Articles

Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial.

Thomsen A, Monroy Ordonez E, Henke M, Luka B, Sahlmann J, Schafer H Clin Transl Radiat Oncol. 2025; 51:100915.

PMID: 39898328 PMC: 11783056. DOI: 10.1016/j.ctro.2025.100915.


Single Nucleotide Polymorphisms as Biomarker Predictors of Oral Mucositis Severity in Head and Neck Cancer Patients Submitted to Combined Radiation Therapy and Chemotherapy: A Systematic Review.

Cavalieri R, Oliveira H, Louvain de Souza T, Kanashiro M Cancers (Basel). 2024; 16(5).

PMID: 38473311 PMC: 10931025. DOI: 10.3390/cancers16050949.


Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.

San Valentin E, Do K, Yeung S, Reyes-Gibby C Int J Mol Sci. 2023; 24(23).

PMID: 38069314 PMC: 10706892. DOI: 10.3390/ijms242316995.


Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review.

Nicol A, Ching J, Tam V, Liu K, Leung V, Cai J Cancers (Basel). 2023; 15(23).

PMID: 38067408 PMC: 10705154. DOI: 10.3390/cancers15235705.


Lack of association between XRCC1 SNPs and acute radiation‑induced injury or prognosis in patients with nasopharyngeal carcinoma.

Zheng Y, Zong J, Chen Y, Guo J, Lu T, Xin X Oncol Lett. 2023; 26(6):544.

PMID: 38020297 PMC: 10660173. DOI: 10.3892/ol.2023.14130.


References
1.
Guo Z, Wang Y, Zhao Y, Jin Y, An L, Wu B . Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients. Oncotarget. 2017; 8(37):62286-62297. PMC: 5617505. DOI: 10.18632/oncotarget.19725. View

2.
Westra H, Peters M, Esko T, Yaghootkar H, Schurmann C, Kettunen J . Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013; 45(10):1238-1243. PMC: 3991562. DOI: 10.1038/ng.2756. View

3.
Cox J, Stetz J, Pajak T . Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31(5):1341-6. DOI: 10.1016/0360-3016(95)00060-C. View

4.
Lin J, Jan J, Hsu C, Liang W, Jiang R, Wang W . Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003; 21(4):631-7. DOI: 10.1200/JCO.2003.06.158. View

5.
Sagan D, Mortl S, Muller I, Eckardt-Schupp F, Eichholtz-Wirth H . Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts. Apoptosis. 2007; 12(4):753-67. DOI: 10.1007/s10495-006-0021-0. View